High-performance PCR platforms optimized for rapid clinical and field deployment.
Uruguay, recognized as a leader in Latin American biotechnology and agricultural exports, presents a sophisticated landscape for Multiplex Diagnostic Systems. As the country intensifies its focus on "One Health" initiatives—integrating human, animal, and environmental health—the demand for high-throughput, multi-pathogen detection platforms has reached an all-time high. The Uruguayan livestock sector, particularly in regions like Salto, Tacuarembó, and Durazno, requires robust Veterinary PCR solutions to maintain its prestigious "Foot and Mouth Disease Free" status and ensure the traceability of its beef exports to global markets including the EU and USA.
Globally, the molecular diagnostics industry is shifting from single-target assays to Syndromic Testing. This transition allows clinicians and researchers to identify multiple pathogens from a single sample, drastically reducing time-to-result and improving patient outcomes. BioX Medical, as a premier manufacturer, bridges the gap between high-end laboratory performance and field-ready portability, serving the unique geographical needs of Uruguay’s decentralized healthcare and agricultural research network.
Utilizing our 9,000 sqm facility in Shenzhen, we implement aerospace-grade optical calibration for every 4-6 channel PCR analyzer exported to Uruguay.
Detect up to 6 targets simultaneously, optimizing sample utilization and reagent costs—a critical factor for Uruguayan clinical labs.
Our systems are designed to align with LATU (Laboratorio Tecnológico del Uruguay) and MGAP (Ministerio de Ganadería, Agricultura y Pesca) standards.
Innovating the next generation of molecular diagnostic intelligence.
The future of diagnostics in Uruguay lies in Digital PCR (dPCR) and the integration of Artificial Intelligence (AI) for automated data interpretation. BioX Medical is currently pioneering a technical roadmap that includes:
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation. BioX Medical serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America (specifically Uruguay), and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.
High-throughput platforms and specialized kits for Uruguay's leading research labs.
Uruguay's strategic position within MERCOSUR requires a diagnostic infrastructure that is both agile and highly accurate. BioX Medical provides tailored solutions that address three core macro pillars:
Providing clarity on Multiplex Diagnostic Systems for our Uruguayan partners.
Multiplex PCR allows for the simultaneous detection of multiple pathogens (e.g., Respiratory panels or Bovine diarrhea panels) from a single sample. In Uruguay, where logistics can be costly in rural areas, this reduces costs per test and provides a faster clinical picture for veterinarians and doctors.
Yes, all our exported units to Uruguay are configured for 220V/50Hz and feature standard Ethernet/USB connectivity. We also offer cloud integration options that work with Uruguay's robust 4G/5G mobile network for field operations.
We offer comprehensive remote technical support and local distributor training. Our diagnostic systems feature remote diagnostics, allowing our Shenzhen-based engineers to troubleshoot software issues in real-time for our Uruguayan clients.
Our platforms are open-system or closed-system compatible. While we provide standard kits, our Multiplex Nucleic Acid Detection platforms can be programmed with customized primers and probes developed specifically for South American genetic variants of pathogens.